Harvard Medical School
The Analysis published in Archive of Ophthalmology reports that there is assotiation between woman, who take postmenopausal hormones and risk developping bound age macular degenerations. Diane Feskanich, Sc.D., Brigham And Hospital of the Women and Harvard Medical School, Boston and colleagues found that, for womans particularly, who have taken spoken contraceptive, postmenopausal hormones reduced risk to develop on given stages disease eye.
Amongst more old adult, bound age macular degenerations (AMD) - a main reason of the blindness and loss of the vision. The Condition responsible for deep loss of the vision on 1.75 million American. Record “Though genetics is played key role in receptivity on AMD, environmental factor such as, smoking, - also important,” Feskanich and colleagues. “Acknowledgement of the higher rateses AMD in woman than in man and reference between AMD and disease offered the role for estrogen,” in as disease works.
The Researchers used given from Analysis of Health Sester to analyse AMD and factors referred to estrogen such as, postmenopausal use the hormone, spoken contraceptive use, age menarche (the first period) and menopause, and history sort. 74,996 Posts-womans menopausal in sample, 554 and 334 designed commencing-stage and neovascular AMD, accordingly, between 1980 and 2002. The Stage neovascular AMD is more leading and result in development new blood.
The Researchers found that, “Current postmenopausal users of the hormone had notable 48 percents of the more low risk neovascular AMD in contrast with that who never used postmenopausal hormones though risk did not be rejected(deviate) with more long duration of the use linear. The Risk was the most low for postmenopausal users of the hormone, which used spoken contraceptive in past.”
However, spoken contraceptive use was not bound in early risk AMD, and current postmenopausal users of the hormone were 34% more probably to develop the early stage AMD than not-users. Record ” more high risk early AMD amongst postmenopausal users of the hormone was unexpected and in evident conflict with observed inverse assotiation for neovascular AMD,” researchers.
Besides, researchers found 26% more low risk early AMD amongst womans, who give birth.
The Authors solve this, “Taken together, these information offer the role for estrogen in pathogenesis AMD, which requires to promote the study in specific early and last sign disease.”